Omnicuris Logo
The Hidden Economic Burden of Heart Failure in India

The Hidden Economic Burden of Heart Failure in India

Read More
Full Text
Last week

The Hidden Economic Burden of Heart Failure in India


Heart failure treatment costs in India are reaching a breaking point for many families across the country. Consequently, a recent nationwide study has highlighted a stark reality for those living with this chronic condition. Published in the journal Global Heart, the research reveals that seven out of 10 heart failure patients lack any form of financial protection. Therefore, most families are forced to bear the massive financial weight of medical care entirely from their personal savings.



The Reality of Out-of-Pocket Heart failure treatment costs


On average, a patient in India spends more than ₹1 lakh annually on managing heart failure. Furthermore, the study indicates that over 90% of these expenses are paid directly by the patients. This high level of out-of-pocket spending exposes a significant gap in the Indian healthcare system regarding chronic illness support. Additionally, nearly one in three patients reported a substantial drop in their monthly earnings after diagnosis. Patients often stop working due to their health status, while family members frequently cut back on employment to provide necessary care. As a result, the financial burden is not limited to medical bills but extends to a loss of household income.



Catastrophic Spending and Clinical Outcomes


Approximately 38% of households affected by heart failure experience catastrophic health spending. Specifically, this means healthcare costs overwhelm the family's total capacity to pay for basic needs. Moreover, nearly one in six families must borrow money or sell their physical assets to sustain treatment. This economic distress often leads to poor clinical outcomes. When funds are low, patients frequently skip essential medications or delay follow-up appointments with their cardiologists. Consequently, these delays increase the risk of repeated hospitalisations, which are far more expensive than routine outpatient care. Therefore, addressing affordability is crucial for improving long-term survival rates in India.



The Need for Comprehensive Insurance Coverage


Current insurance schemes, including Ayushman Bharat, primarily focus on hospitalisation and acute procedures. However, heart failure is a chronic disease that requires lifelong management and expensive medications. Most existing policies do not adequately cover the costs of outpatient visits, diagnostic tests, and daily drugs. Specifically, newer therapies have improved quality of life but remain unaffordable for the uninsured population. Expanding insurance to include structured follow-up care and long-term medication is essential. By providing better financial protection, the healthcare system can reduce the burden on rural and low-income families. Furthermore, this shift will likely improve patient adherence and reduce the overall national cost of heart failure management.



Frequently Asked Questions


Q1: What is the average annual cost of heart failure treatment in India?


The average annual out-of-pocket cost for heart failure treatment in India is approximately ₹1.06 lakh. This figure accounts for nearly 93% of the total healthcare expenditure for most patients.


Q2: Why is current health insurance often insufficient for heart failure?


Most insurance schemes in India cover hospitalisation but fail to provide adequate support for outpatient care. Since heart failure requires lifelong medication and regular follow-ups, these uncovered costs create a massive financial strain.


Q3: How many patients in India are affected by catastrophic health spending?


Approximately 38% of heart failure patients in India face catastrophic health spending, often forcing them to borrow money or sell assets to afford their medical treatment.



Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.



References



  1. 7 in 10 heart failure patients in India lack financial cover; treatment costspush families to brink - ETHealthworld

  2. Jeemon, P., et al. (2026). Financial Burden, Out-of-Pocket Health Spending, and Household Economic Well-Being in Heart Failure Patients in India. Global Heart.

  3. The Hindu. (2026). Study reveals devastating financial burden on heart failure patients in India.

Login to continue

More from MedShots Daily

The Hidden Economic Burden of Heart Failure in India
The Hidden Economic Burden of Heart Failure in India

Study finds 7 in 10 Indian heart failure patients lack insurance, with average annual costs exceeding ₹1 lakh, leading to catastrophic financial distress....

Last week

Read More
Full Text
Primary Aldosteronism: Imaging Matches Aldosterone Source in Only Half of Cases
Primary Aldosteronism: Imaging Matches Aldosterone Source in Only Half of Cases

A study by Mermejo et al. reveals that cross-sectional imaging often fails to accurately identify aldosterone sources in lateralized primary aldosteronism....

Today

Read More
Full Text
Early Life Exposure to Flame Retardants Linked to Long-Term Stress Dysregulation
Early Life Exposure to Flame Retardants Linked to Long-Term Stress Dysregulation

Study reveals that perinatal exposure to organophosphate flame retardants leads to lasting, sex-specific HPA axis dysregulation and behavioral changes in mi...

Today

Read More
Full Text
Telangana's Healthcare Crisis: Why Costs are Skyrocketing
Telangana's Healthcare Crisis: Why Costs are Skyrocketing

Telangana leads India in treatment costs for major illnesses, with cardiac care and infections being significantly higher than the national average....

Today

Read More
Full Text
Digital Transformation in Prosthetics: Assessing Workflow Tool Acceptance
Digital Transformation in Prosthetics: Assessing Workflow Tool Acceptance

Qualitative study on the Life Lounge Clinical Workflow tool's acceptance and perceived benefits among prosthetists and orthotists in Sweden....

Today

Read More
Full Text
OGR1 Identified as Key Regulator of PTH Secretion in Acidic Environments
OGR1 Identified as Key Regulator of PTH Secretion in Acidic Environments

Researchers identify OGR1 as the primary proton sensor mediating PTH secretion during acidosis, highlighting a novel target for chronic kidney disease thera...

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris
Heart failure treatment costs in India: Financial strain | Omnicuris